Clinical Trial: A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06897813) titled 'A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants' on March 04.

Brief Summary: This is a phase I, randomised, double-blind, placebo-controlled, 3-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of WD-910 in in Healthy Participants Detailed

Study Start Date: June 30, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: WD-910 tablet

Administered P.O.

DRUG: WD-910 Tablets Place...